Think Radial®—Join Us to Explore What’s New in Transradial Access
As medical technology rapidly evolves, it’s vital that physicians have access to training to match the pace. Merit Medical’s Think Radial® education program is renowned for providing advanced, highly specialized training to physicians across the globe in both live and virtual formats.
Hear from our knowledgeable proctors, preview session highlights, and learn about how you can get involved.
Why Think Radial?
Think Radial courses offer hands-on training for proximal and distal radial access for interventionalists in multiple specialties, including cardiology, radiology, neurology, and nephrology. These procedures are one of the medical field’s most exciting innovations—not only for physicians, but as an alternative to femoral access for patients.
Potential advantages of distal radial access may include lessened risk of hematoma while maintaining hand functionality for patients, and for operators, may supply enhanced ergonomics and comfort during the procedure. On average, it also requires less intensive post-procedural care from nurses and support staff.
“Now more than ever there are so many ways to consume medical information,” says Sandeep Nathan, MD, MSc, FACC, FSCAI, interventional cardiologist at the University of Chicago and Think Radial proctor. “It behooves us to use those resources to evolve in our careers and procedures certainly, but most importantly, to do right by our patients.”
This emphasis on improving care for patients is a major driver of physician education programs like Think Radial. New technology and methods can provide more healthcare options, including less invasive procedures and reduced pain.
“Physician education allows us to remain at the forefront of knowledge,” says Darren Klass, MD, PhD, MRCS, FRCR, FRCPC, interventional radiologist at the Vancouver General Hospital and Think Radial proctor. “In many instances, the procedure itself may not fundamentally change; however, new techniques and equipment that make the procedure safer and more effective can improve patient outcomes.”
What to Expect from Your Think Radial Course
Merit’s Think Radial program focuses on cutting-edge education to facilitate advanced therapies. Our proctors go beyond lecturing—designed to be fully immersive, our course provides the hands-on experience physicians need. With insightful presentations and demonstrations, course attendees can look forward to the following interventional cardiology, radiology, and neuroradiology agenda:
- Specialty breakout sessions
- Patient prep workflow
- Catheter selection
- Hands-on cadaver ultrasound and access
- New technology review
- Tips/tricks to enhance your procedures
Get Involved
Reach out to your Merit rep and follow us on social media for information on the latest course offerings. Interventional cardiologists, interventional radiologists, interventional neuroradiologists, interventional nephrologists, vascular surgeons, and fellows from each specialty will benefit most from attending.
Discover how our Think Radial program can benefit you, and explore more of our overall Think Education™ program. We look forward to welcoming you to our campus or seeing you online.
407306001_001
Merit Medical to Exhibit at CIRSE 2022
Merit Medical will be exhibiting at CIRSE 2022, the Cardiovascular and Interventional Radiological Society of Europe’s Annual Congress. Join our team September 10-13 in Barcelona, Spain, for a high-quality, four-day educational program with an international audience, in-person training, and hands-on workshops.
This year, we’re hosting a valuable Satellite Symposium as well as daily Learning Center Program sessions with topics tailored to meet a wide range of clinical needs. We also have an exciting lineup of leading-edge products designed to improve patient outcomes.
Here’s a summary of what you can expect from us at CIRSE 2022:
Satellite Symposium
Listen in on this valuable panel discussion featuring thought leaders from across the globe. Lunch bags will be provided.
Topic:
Expanding Patient Access with Merit WRAPSODY™, the Cell-Impermeable Endoprosthesis Designed to Meet the Clinical Challenges of AVF & AVG Interventions
Date: September 13, 2022
Time: 13:00-14:00 CEST
Location: Room 115
Lectures and Faculty
WRAPSODY Cell-Impermeable Endoprosthesis: Why Develop the Next Generation Covered Stent?
Recorded Case: Successful Treatment of a Challenging AV Stenosis with WRAPSODY Cell-Impermeable Endoprosthesis
Case Presentations—the Value of WRAPSODY Cell-Impermeable Endoprosthesis in Treating Challenging AV Dysfunctions—Part 1
Case Presentations—the Value of WRAPSODY Cell-Impermeable Endoprosthesis in Treating Challenging AV Dysfunctions—Part 2
Case Presentations—How I Reduce Reintervention Rates in My Practice with WRAPSODY Cell-Impermeable Endoprosthesis
Learning Objectives
- Explore how experts utilize the features of WRAPSODY for optimal clinical outcomes.
- Discover the benefits of using a cell-impermeable endoprosthesis through challenging real-case discussions.
- Understand the economic impact of using a cell-impermeable endoprosthesis at early stages.
The Merit Learning Center
Explore the following daily lectures and hands-on sessions. Please join us early; space is limited!
TOPIC | FACULTY | DATE / TIMES | OBJECTIVE |
---|---|---|---|
Embolize with Experts ǀ UAE Latest News. Ovarian Protection, Fertility & Adenomyosis | Dr. Olivier Serres Cousiné (Montpellier/FR) | Sat, Sept 10, 2022 – 13:30–14:15 CEST | Explore the latest clinical evidence on uterine artery embolization. |
Embolize with Experts ǀ First International Prostate Registry: What Are the Clinical Data Telling Us? | Prof. Marc Sapoval (Paris/FR) | Sat, Sept 10, 2022 – 15:00-15:45 CEST | Review preliminary results of a prostate multicenter registry, followed by a “How I Do It” discussion. |
The Art of dTRA ǀ Distal Radial Access Technique in Peripheral Intervention | Dr. Darren Klass (Vancouver/CA) | Sun, Sept 11, 2022 – 09:00–09:45 CEST – 11:00–11:45 CEST | Discuss why choosing distal transradial access first expands access options for interventionalists in peripheral procedures. Discover best practices in distal radial access and hemostasis and how this improves patient care. |
Advanced Outcomes Made Simple ǀ Liver and Lung Biopsy with the New TEMNO Elite™ Needle | Dr. Damian Mullan (Manchester/UK) | Sun, Sept 11, 2022 – 13:30–14:15 CEST – 15:00–15:45 CEST | Explore unique key features of the new TEMNO Elite Biopsy System and how these will benefit liver and lung biopsy procedures. |
The Art of dTRA ǀ Distal First: Advancing Vascular Access | Dr. Ferdinand Kiemeneij (Tergooi/NL) | Mon, Sept 12, 2022 – 09:00–09:45 CEST – 11:00–11:45 CEST | Discuss choosing distal transradial access as a first option. Review data and literature highlighting why it should be the default vascular access site and its safety. |
Advanced Outcomes Made Simple ǀ Swift Decision Making: When SwiftNINJA® Should Be Used to Overcome Tricky Procedures | Prof. Mark Little (Berkshire/UK) | Mon, Sept 12, 2022 – 13:30–14:15 CEST | Find how using SwiftNINJA first will simplify and shorten procedures. |
Maximum Results. Fast Recovery ǀ Venous Leg Ulcer: NTNT Treatment Option | Mr. Leith Williams (Wirral/UK) | Tues, Sept 13, 2022 – 09:00–09:45 CEST – 11:00–11:45 CEST | Explore an innovative approach to treating venous leg ulcers, including the benefits of treating advanced venous disease with non-thermal, non-tumescent technique. |
Hands-on Device Training
Discover multiple exclusive sessions organized by CIRSE.
Learning Objectives
- Discover available devices and technical specifications for the given topic.
- Obtain basic knowledge about the manipulation of the different devices.
Sessions and Faculty
TOPIC | FACULTY | DATE / TIMES | LOCATION |
---|---|---|---|
Tumor Ablation (RFA) | Prof. Jean-Yves Gaubert (Marseille/FR) and Dr. Maria Tsitskari (Nicosia/CY) | Sun, Sept 11, 2022 – 09:45-11:15 CEST – 12:45-14:15 CEST – 17:30-18:30 CEST | Room 111 |
Vertebral Augmentation | Dr. Paul N.M. Lohle (Tilburg/NL) and Prof. Kai E. Wilhelm (Bonn/DE) | Mon, Sept12, 2022 – 09:45-11:15 CEST – 12:45-14:15 CEST | Room 132 |
Embolization: Materials & Tools (Particulate Agents) | Prof. Bernhard Gebauer (Berlin/DE) and Prof. Stavros Spiliopoulos (Athens/GR) | Tues, Sept 13, 2022 – 09:45-11:15 CEST – 12:45-14:15 CEST | Room 134 |
Varicose Veins | Dr. John M. Regi (Sheffield/GB) and Dr. Filipe Veloso Gomes (Lisbon/PT) | Tues, Sept 13, 2022 – 09:45-11:15 CEST – 12:45-14:15 CEST | Room 132 |
Advanced Merit Technologies
Visit us at the Merit booth 47 and the Learning Center to explore what our advanced technologies can bring to your procedures.
Achieve superior samples with the TEMNO Elite Biopsy System, a device that obtains samples 72% larger than competitor side-notch, semi-automatic devices.1
The most clinically studied spherical embolic, Embosphere is the clear choice among interventional radiologists. Designed for predictable and durable occlusion for the embolisation of symptomatic uterine fibroids, AVMs, and hypervascular tumours, the elastic material allows for temporary compression of up to 33%,3 yielding targeted results for patients and practitioners.
SwiftNINJA® Steerable Microcatheter
The SwiftNINJA is an innovative straight-tip catheter featuring an ergonomic steering dial that navigates up to 180 degrees and enables in vivo control. Consisting of a hydrophilic-coated distal 80 cm, the device delivers exceptional precision and speed navigating even in the most challenging vascular ostium.
ClariVein® OC Infusion Catheter
A minimally invasive solution for patients, the ClariVein OC Infusion Catheter features a unique 360-degree rotatable dispersion wire at the distal end. The catheter design has been engineered with a small profile, exceptional flexibility, strong imaging visualisation, and excellent pushability.
Please Note: The ClariVein OC Infusion Catheter is not available for sale or use within the United States.
Merit WRAPSODY Cell-Impermeable Endoprosthesis
Featuring a unique tri-layered endoprosthesis microstructure, the Merit WRAPSODY Cell-Impermeable Endoprosthesis extends long-term vessel patency in patients who experience obstructions in the dialysis outflow circuit. The hydrophilic coating allows pinpoint accuracy, smooth insertion, and withdrawal with top-tier trackability.
Please Note: The Merit WRAPSODY Cell-Impermeable Endoprosthesis is not available for sale or use within the United States.
We look forward to meeting you at CIRSE 2022 and discussing how our products and services can bring advantages to your practice. See you in Barcelona!
Questions? Contact our Customer Support Center, and speak to one of our representatives. Live chat, phone, or email—we’re here for you.
Don’t forget to follow us on social media for live conference updates!
Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.
REFERENCES
- Internal testing with 18G. Data on File. Marketing Claims for the TEMNO Elite Device (ECN147270).
What To Expect from Merit at SIR 2022 – “Advanced Outcomes Made Simple”
Merit will be exhibiting at SIR 2022, the Society of Interventional Radiology’s Annual Scientific Meeting. Join us June 12 – 14 in Boston, MA, for a high-quality educational program with an international audience, in-person training, and hands-on workshops. Along with showcasing an exciting lineup of leading-edge products, this year we’re hosting a Lunch & Learn session you won’t want to miss.
Here’s a sneak peek of what you can expect at booth #418:
LUNCH & LEARN
Lunch is on us! We hope to see you Monday, June 13 at 12:00 PM EDT for the following educational presentation:
Case-Based Discussion of Steerable Technology in Treatment of VCF and Spinal Metastatic Disease
DATE: Monday, June 13
TIME: 12:00 pm EDT
WHERE: Booth #418
LEARNING OBJECTIVES:
- Understand Clinical & Procedural Value of Steerable Devices
- Discover Therapy-Awareness Strategies
- Engage in Case-Based Discussion and Q&A
FACULTY
Dana Dunleavy, M.D.
Windsong Radiology Director of Interventional & Vascular Services
Buffalo, NY
Learn more about Dr. Dunleavy
PRODUCT SHOWCASE AT BOOTH #418
NEW Prelude Roadster™ Guide Sheath
Expand your diagnostic and interventional procedures with the new Prelude Roadster, a longer guide sheath designed to access difficult anatomy in the peripheral vasculature. Stop by booth #418 to be among the first to discover this brand-new technology.
ReSolve® Thoracostomy Tray
The ReSolve Thoracostomy Tray allows air (pneumothorax) and fluid (pleural effusion) to be drained from the pleural space through a percutaneous approach rather than an open surgical approach, providing your patients with minimally invasive care.
TEMNO Elite™ Biopsy System
The TEMNO Elite Biopsy System offers the reliability you expect with new features designed to provide superior soft tissue samples and total procedure control.
SplashWire™ Hydrophilic Steerable Guide Wire
The Merit SplashWire combines optimum lubricity, exceptional torque response, and enhanced visibility, helping you achieve the successful outcomes you expect for your patients. We designed the SplashWire to successfully perform in the most complex cases.
ReSolve ConvertX® Nephroureteral & Biliary Stent System
Drain to stent in 30 seconds1 with the ConvertX. Designed to treat ureteral and biliary obstructions, you can place it like any internal-external drain, then convert it to a stent when you’re ready.
Surfacer® Inside-Out® Access Catheter System
Pioneered by interventional cardiologist John Gurley, M.D., the Inside-Out approach was developed in response to patients with chronically occluded veins that required life-saving vascular access. Inserted in the femoral vein, the Surfacer Inside-Out Access Catheter System locates an exit from the right internal jugular vein, maintaining viable secondary veins if necessary.
See the Surfacer featured on the cover of June 2022 Journal of Vascular Surgery.
One-Vac™ Evacuated Drainage Bottle
Engineered with an advanced design, the One-Vac is the smart option when choosing an evacuated drainage bottle. Built with a number of key features, the One-Vac makes percutaneous fluid collection and discard simple, efficient, and safe for you and your patients.
EmboCube® Embolization Gelatin
Specifically designed for embolization of hypervascular tumors and blood vessels to occlude blood flow, EmboCube controls hemorrhaging in the peripheral vasculature. Gelatin is cut uniformly in preloaded 1-mL or 3-mL Medallion® Syringes to help ensure seamless prep and accurate delivery.
Embosphere® Microspheres
The most clinically studied spherical embolic, Embosphere is the clear choice among interventional radiologists. Designed for predictable and durable occlusion for the embolization of symptomatic uterine fibroids, AVMs, and hypervascular tumors, the elastic material allows for temporary compression of up to 33%3, yielding targeted results for patients and practitioners.
Merit Maestro® Microcatheters
A multipurpose microcatheter, the Maestro is designed to deploy coils up to 0.018″ and embolics up to and including 900 µm. A swan neck design helps you seat the catheter in the vessel, reducing the recoiling effect.
SwiftNINJA® Steerable Microcatheter
The SwiftNINJA is an innovative straight-tip catheter featuring an ergonomic steering dial that navigates up to 180 degrees and enables in vivo control. Consisting of a hydrophilic-coated distal 80 cm, the device delivers exceptional precision and speed even when you’re navigating the most challenging vascular ostium.
Prelude IDeal™ Hydrophilic Sheath Introducer
A hydrophilic access sheath with increased kink and compression resistance makes the IDeal the tool of choice for your radial access procedures.
Arcadia™ Steerable Balloon-Assisted Vertebral Augmentation
The Arcadia is designed to achieve controlled, precise, targeted cavity creation in your vertebral augmentation procedures—whether your approach is unipedicular or bipedicular.
NEW AT MERIT: Arcadia™ Curved Delivery Cannula
Stop by booth #418 and ask us about our NEW Arcadia™ Curved Delivery Cannula—a bone cement delivery system designed for predicable cement deposition across the midline of the vertebral body, optimizing cement volume, while potentially reducing the need for bipedicular access.
STAR™ Tumor Ablation System
STAR delivers meaningful pain relief and localized tumor destruction in a single treatment. Your patients will appreciate that this mechanism is designed to perform successfully and comfortably in an outpatient setting.
We look forward to seeing you at SIR 2022 and discussing all the ways we can help you enhance your patient care. Questions? Contact our Customer Support team and speak to one of our representatives. Live chat, phone, or email—we are here for you.
Don’t forget to follow us on social media for live conference updates!
Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.
REFERENCES
- Data on File.
- Laurent et al. Am J Neuroradial 1996.
Join Merit Medical for Hands-on Workshops at the European Vascular Course 2022
Merit will be exhibiting at the European Vascular Course, held from 12 – 14 June in Maastricht. The course will celebrate its 25th anniversary and will comprise more than 300 workshops. Our team will be showcasing cutting-edge technologies and hosting seven experiential hands-on workshops. Please register for our workshop program via www.vascular-course.com. We look forward to seeing you in person at booth #28 and training room #2.4!
Check out what the Merit team has in store for attendees:
PHYSICIAN EDUCATION
Serious Challenges in the Dialysis Access Circuit: What Treatment Options Would You Choose and Why?
Course Option 1:
- DATE: Sunday, 12 June
- TIME: 16:30 – 18:00 CEST
Course Option 2:
- DATE: Tuesday, 14 June
- TIME: 09:00 – 10:30 CEST
Faculty:
- Mr. James Gilbert, Transplant & Vascular Access Surgeon, Oxford, UK
Learning Objectives:
- Understand development in dialysis access
- Provide options in complex, unusual, and desperate access situations
- Learn treatment and patient algorithm
- Increase knowledge and skill set on the use of the Merit WRAPSODY™ Cell-Impermeable Endoprosthesis, HeRO® Graft, and Surfacer® Inside-Out® procedures
Attendees: This training session is designed for physicians with an interest in difficult ESRD access with patients who have central venous stenosis and central venous occlusion: vascular surgeons, interventional radiologists, and nephrologists.
How Low Can You Go? Benefits of Treating to the Lowest Point of Incompetence.
Course Option 1:
- DATE: Sunday, 12 June
- TIME: 10:00 – 11:00 CEST
Course Option 2:
- DATE: Monday, 13 June
- TIME: 16:00 – 17:00 CEST
Faculty:
- Mr. Leith Williams, Vascular Surgeon, Wirral, UK
Learning Objectives:
- Understand the benefits of treating advanced venous disease with non-thermal, non-tumescent (NTNT) technique
- Learn an innovative approach to treat VLU
- Experience a practical approach to the ClariVein® OC device and the procedure
Attendees: This training session is designed for physicians with an interest in chronic venous insufficiency and phlebology: vascular surgeons, interventional radiologists, phlebologists, angiologists, dermatologists, and physician associates.
Tackle Common Procedural Challenges: Wires, Catheters, and Snares—Which Are the Best Options?
Course:
- DATE: Sunday, 12 June
- TIME: 13:00 – 14:30 CEST
Faculty:
- The Merit Education Team
Learning Objectives:
- Learn the basics of diagnostic wires, catheters, and snares
- Understand how to differentiate between Teflon wires and hydrophilic wires
- Explore how to cannulate visceral and cerebral vessels by using different wires and catheters as well as the removal of foreign objects
Attendees: This training session is designed for residents with an interest in interventional radiology.
Distal First? What’s New in Transradial Access.
Course:
- DATE: Monday, 13 June
- TIME: 12:00 – 13:30 CEST
Faculty:
- The Merit Education Team
Learning Objectives:
- Understand proximal and distal radial access as well as how it impacts practices
- Learn ultrasound access techniques with POV instruction, haemostasis, and avoid common pitfalls
- Comprehend case selection and patient prep workflow
Attendees: This training session is designed for physicians with an interest in radial and distal radial access: interventional cardiologists, interventional radiologists, neurointerventional radiologists, and interventional nephrologists.
Vascular Access Nurse—What Is the Latest ESRD Access That Can Benefit Patients with Failing Fistulas and Grafts?
Course:
- DATE: Monday, 13 June
- TIME: 09:20 – 11:00 CEST
Faculty:
- The Merit Education Team
Learning Objectives:
- Understand development in dialysis access
- Support vascular wellness best practice
- Improve vascular access care for patients
Attendees: This training session is designed for nurses with an interest in difficult ESRD access with patients who have central venous stenosis and central venous occlusion.
PRODUCT SHOWCASE AT BOOTH 28
HeRO® Graft
The HeRO Graft, a hemodialysis access graft designed for catheter-dependent patients or those failing fistulas or other grafts, offers a 69% reduction in future infections compared to patients receiving catheters as well as a cost-saving of 23% on average per year.
Surfacer® Inside-Out® Access Catheter System
Pioneered by interventional cardiologist John Gurley, M.D., the Inside-Out approach was developed in response to patients with chronically occluded veins that required life-saving vascular access. Inserted in the femoral vein, the Surfacer® Inside-Out® Access Catheter System locates an exit from the right internal jugular vein, maintaining viable secondary veins if necessary.
See the Surfacer featured on the cover of June 2022 Journal of Vascular Surgery.
Merit WRAPSODY™ Cell-Impermeable Endoprosthesis
Featuring a unique tri-layered endoprosthesis microstructure, the Merit WRAPSODY Cell-Impermeable Endoprosthesis extends long-term vessel patency in patients who experience obstructions in the dialysis outflow circuit. The hydrophilic coating allows pinpoint accuracy, smooth insertion, and withdrawal with top-tier trackability.
Please Note: The Merit WRAPSODY Cell-Impermeable Endoprosthesis is not available for sale or use within the United States.
ClariVein® OC Infusion Catheter
A minimally invasive solution for patients, the ClariVein® OC Infusion Catheter features a unique 360-degree rotatable dispersion wire at the distal end. The catheter design has been engineered with a small profile, exceptional flexibility, strong imaging visualization, and excellent pushability.
Please Note: The ClariVein OC Infusion Catheter is not available for sale or use within the United States.
Merit MAK™ Mini Access Kit
To access the vascular system, Merit MAK Mini Access Kits take a very small approach, minimizing bleeding and trauma for the patient. Merit MAK guide wires are carefully engineered with a fully enclosed hoop and available in several configurations. Each kit includes a coaxial introducer/dilator pair, 21G needle, and guide wire.
Merit is committed to offering healthcare professionals the technologies and education opportunities they need to improve patient care. We are proud to participate in EVC 2022 and look forward to seeing you in person. Register for EVC and all workshops at www.vascular-course.com.
Merit WRAPSODY™ Endoprosthesis and ClariVein® OC are not approved or available for sale in the United States.
Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.
REFERENCES
- Katzman et al., J Vasc Surg 2009.
- Dageforde et al., JSR 2012.
Join Merit Medical for Educational Sessions and Live Case Transmission at LINC 2022
We look forward to attending the Leipzig Interventional Course (LINC), held from 6 to 9 June, in person and online. Our team will be hosting a satellite symposium with live case transmission and several on-demand learning centre sessions. Attendees can also visit Merit booth #39 to explore multiple product innovations.
Mark your calendars—here’s an outline of what we have planned:
SATELLITE SYMPOSIUM
DATE: Monday, 6 June
TIME: 15:50 – 17:05 CEST
WHERE: Main Arena 2 & Online
LEARNING OBJECTIVES
- Follow an overview on the evolution of covered stents
- Learn more about the current WRAPSODY trial pipeline (FIRST, IDE, and Registry)
- Understand how to manage patients and how to decide their best treatment options (i.e., treatment algorithm)
- Discover how the WRAPSODY can be beneficial and cost effective in daily treatment
AGENDA
TIME | DESCRIPTION | FACULTY |
15:50 – 15:53 | Introduction by the moderator | Prof. Dr. Fabrizio Fanelli |
15:53 – 16:04 | The evolution of covered stents | Dr. Tobias Steinke |
16:04 – 16:16 | Live case transmission from Varese University of Insubria | Prof. Dr. Matteo Tozzi |
16:16 – 16:27 | Clinical trials: WRAPSODY FIRST, IDE, and Registry | Prof. Dr. Dheeraj Rajan |
16:27 – 16:39 | Recorded case presentation | Dr. Tobias Steinke |
16:39 – 16:50 | The algorithm for covered stent treatment | Dr. Ounali Jaffer |
16:50 – 17:00 | Health economics in covered stent management: An overview | Prof. Katarzyna Kolasa |
17:00 – 17:05 | Final Q&A and wrap-up |
LEARNING CENTRE SESSIONS
CENTRE 1
Rethinking AVF Management: WRAPSODY, the Cell-Impermeable Endoprosthesis in Challenging AV Access Repair
Faculty:
- Dr. Tobias Steinke, Vascular Surgeon, Schön Klinik, Dusseldorf, Germany
- Dr. Andrew Wigham, Interventional Radiologist, Churchill Hospital, Oxford, United Kingdom
CENTRE 2
Transradial TACE with HepaSphere™ Microspheres: A Journey from Patient Selection to Outcome
Faculty:
- Dr. Darren Klass, Clinical Associate Professor, University of British Columbia, Vancouver, Canada; Consultant Radiologist, Cleveland Clinic, London, United Kingdom
CENTRE 3
ClariVein® OC Procedural Video
Faculty:
- Mr. Leith Williams, Vascular Surgeon, Wirral, United Kingdom
PRODUCT SHOWCASE IN BOOTH 39
HeRO® Graft
The HeRO Graft, a hemodialysis access graft designed for catheter-dependent patients or those failing fistulas or other grafts, offers a 69% reduction in future infections compared to patients receiving catheters as well as a cost-saving of 23% on average per year.
Surfacer® Inside-Out® Access Catheter System
Pioneered by interventional cardiologist John Gurley, M.D., the Inside-Out approach was developed in response to patients with chronically occluded veins that required life-saving vascular access. Inserted in the femoral vein, the Surfacer® Inside-Out® Access Catheter System locates an exit from the right internal jugular vein, maintaining viable secondary veins if necessary.
See the Surfacer featured on the cover of June 2022 Journal of Vascular Surgery.
Merit WRAPSODY™ Cell-Impermeable Endoprosthesis
Featuring a unique tri-layered endoprosthesis microstructure, the Merit WRAPSODY Cell-Impermeable Endoprosthesis extends long-term vessel patency in patients who experience obstructions in the dialysis outflow circuit. The hydrophilic coating allows pinpoint accuracy, smooth insertion, and withdrawal with top-tier trackability.
Please Note: The Merit WRAPSODY Cell-Impermeable Endoprosthesis is not available for sale or use within the United States.
ClariVein® OC Infusion Catheter
A minimally invasive solution for patients, the ClariVein® OC Infusion Catheter features a unique 360-degree rotatable dispersion wire at the distal end. The catheter design has been engineered with a small profile, exceptional flexibility, strong imaging visualization, and excellent pushability.
Please Note: The ClariVein OC Infusion Catheter is not available for sale or use within the United States.
Merit MAK™ Mini Access Kit
To access the vascular system, Merit MAK Mini Access Kits take a very small approach, minimizing bleeding and trauma for the patient. Merit MAK guide wires are carefully engineered with a fully enclosed hoop and available in several configurations. Each kit includes a coaxial introducer/dilator pair, 21G needle, and guide wire.
Embosphere® Microspheres
The most clinically studied spherical embolic, Embosphere is the clear choice among interventional radiologists. Designed for predictable and durable occlusion for the embolisation of symptomatic uterine fibroids, ABMs, and hypervascular tumours, the elastic material allows for temporary compression of up to 33%,3 yielding targeted results for patients and practitioners.
EmboCube® Embolization Gelatin
Specifically designed for embolisation of hypervascular tumours and blood vessels to occlude blood flow, EmboCube consistently controls haemorrhaging in the peripheral vasculature. Gelatin is cut uniformly in preloaded 1-mL or 3-mL Medallion® Syringes to help ensure seamless prep and accurate delivery.
SwiftNINJA® Steerable Microcatheter
The SwiftNINJA is an innovative straight-tip catheter featuring an ergonomic steering dial that navigates up to 180 degrees and enables in vivo control. Consisting of a hydrophilic-coated distal 80 cm, the device delivers exceptional precision and speed navigating even in the most challenging vascular ostium.
We look forward to seeing you at LINC 2022 and presenting all the ways we can partner with you for better patient care. Questions? Contact our Customer Support team and speak to one of our representatives via live chat, phone, or email.
Merit WRAPSODY™ Endoprosthesis and ClariVein® OC are not approved or available for sale in the United States.
Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.
REFERENCES
- Katzman et al., J Vasc Surg 2009.
- Dageforde et al., JSR 2012.
- Laurent et al. Am J Neuroradial 1996.
Join Merit Medical for “The Flow Stops Here” at GEST 2022
Merit will be exhibiting at GEST 2022: Global Embolization Oncology Symposium Technologies. This year’s annual conference features an international audience with in-person training and hands-on workshops in New York, NY. Our theme for this year’s Symposium is The Flow Stops Here, a bold commitment to offering high-quality embolotherapy products and services designed to improve outcomes for physicians and their patients.
PRODUCT SHOWCASE AT BOOTH #801
Embosphere® Microspheres
The most clinically studied spherical embolic, Merit’s Embosphere Microspheres are the clear choice among interventional radiologists. Designed for predictable and durable occlusion for the embolization of symptomatic uterine fibroids, ABMs, and hypervascular tumors, the elastic material allows for temporary compression of up to 33%,1 yielding targeted results for patients and practitioners.
Embocube® Embolization Gelatin
Specifically designed for embolization of hypervascular tumors and blood vessels to occlude blood flow, Embocube Embolization Gelatin consistently controls hemorrhaging in the peripheral vasculature. Gelatin is cut uniformly in preloaded 1-mL or 3-mL Medallion® Syringes to help ensure seamless prep and accurate delivery.
SwiftNINJA® Steerable Microcatheter
The SwiftNINJA Steerable Microcatheter is an innovative straight-tip catheter featuring an ergonomic steering dial that navigates up to 180 degrees and enables in vivo control. Consisting of a hydrophilic-coated distal 80 cm, the device delivers exceptional precision and speed navigating even in the most challenging vascular ostium.
We look forward to seeing you at GEST 2022—where #TheFlowStopsHere!
Questions? Contact our Customer Support Center, and speak to one of our representatives via live chat, phone, or email.
Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.
REFERENCES
- Laurent et al. 1996. “Trisacryl Gelatin Microspheres for Therapeutic Embolization, I: Development and In Vitro Evaluation.” Am J Neuroradial 17:533-540
Merit Medical to Exhibit at HRS 2022: Excellence in EP Access and Lead Management
This week, the EP community is heading to San Francisco for the Heart Rhythm Society (HRS) annual meeting. Friday, April 29 – Sunday, May 1, physicians all over the globe will have access to in-person and online sessions. As a leader in EP and CRM, Merit is thrilled to exhibit cutting-edge technologies and host hands-on physician education, the theme this year: “Excellence in EP Access and Lead Management.”
PRODUCT SHOWCASE AT BOOTH #2034
SafeGuard Focus™ Compression Device
Achieve targeted hemostasis with the SafeGuard Focus, a specialized compression device specifically designed for use in patients with pacemakers and implantable cardioverter defibrillator (ICD) pockets.
HeartSpan® Portfolio
The HeartSpan portfolio – including the HeartSpan Fixed Curve Braided Transseptal Sheath, the HeartSpan Steerable Sheath Introducer, and the HeartSpan Transseptal Needle – offers advanced needles, introducers, and sheaths that work together to assist with ease of femoral insertion, trauma reduction when crossing the atrial septum, and ergonomic support during long procedures.
Worley™ LV Lead Delivery System
To meet the challenges of cardiac resynchronization therapy, the Worley system provides the solutions needed to reduce implantation times, gain easier access to the target vessel, and improve chances for successful implantation.
Vitale™ Occlusion Balloon
The Vitale Occlusion Balloon maintains hemostasis for up to 30 minutes,* allowing time for patients to stabilize and transition to surgery. Faster inflation, faster deflation, and better kink resistance offers better outcomes for you and your patients.
PHYSICIAN EDUCATION
Hands-On Training: I-CRT Tools & Techniques
Faculty: Seth Worley, MD, FHRS, FACC
Date: Saturday, April 30
Time: 12:45PM – 1:30PM PDT
Location: Booth #2034
Merit is committed to offering physicians the technologies and education opportunities they need to improve patient care. We look forward to discussing what we can do for your practice. See you at HRS 2022!
Want up-to-date Merit booth announcements?
Follow us on Twitter and LinkedIn.
Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.
*Data on file.
Merit Medical to Showcase Innovative Products and Participate in Hands-on Workshops at Charing Cross 2022
Merit will be exhibiting at this year’s Charing Cross International Symposium 2022, “the leading vascular symposium where Education, Innovation, and Evidence come together.” This year’s symposium will be offered in-person in London and virtually 26-28 April. Merit is hosting two experiential hands-on workshops and two interactive physician education opportunities.
Find us at booth #16 where we’ll be showcasing the following products:
PRODUCT SHOWCASE
HeRO® Graft
The HeRO Graft, a hemodialysis access graft designed for catheter-dependent patients or those failing fistulas or other grafts, offers a 69% reduction in future infections compared to patients receiving catheters as well as a cost-saving of 23% on average per year.
Surfacer® Inside-Out® Access Catheter System
Pioneered by interventional cardiologist John Gurley, M.D., the Inside-Out approach was developed in response to patients with chronically occluded veins that required life-saving vascular access. Inserted in the femoral vein, the Surfacer® Inside-Out® Access Catheter System locates an exit from the right internal jugular vein, maintaining viable secondary veins if necessary.
Merit WRAPSODY™ Cell-Impermeable Endoprosthesis
Featuring a unique tri-layered endoprosthesis microstructure, the Merit WRAPSODY Cell-Impermeable Endoprosthesis extends long-term vessel patency in patients who experience obstructions in the dialysis outflow circuit. The hydrophilic coating allows pinpoint accuracy, smooth insertion, and withdrawal with top-tier trackability.
Please Note: The Merit WRAPSODY Cell-Impermeable Endoprosthesis is not available for sale or use within the United States.
ClariVein® OC Infusion Catheter
A minimally invasive solution for patients, the ClariVein® OC Infusion Catheter features a unique 360-degree rotatable dispersion wire at the distal end. The catheter design has been engineered with a small profile, exceptional flexibility, strong imaging visualization, and excellent pushability.
Please Note: The ClariVein OC Infusion Catheter is not available for sale or use within the United States.
Merit MAK™ Mini Access Kit
To access the vascular system, Merit MAK Mini Access Kits take a very small approach, minimizing bleeding and trauma for the patient. Merit MAK guide wires are carefully engineered with a fully enclosed hoop and available in several configurations. Each kit includes a coaxial introducer/dilator pair, 21G needle, and guide wire.
PHYSICIAN EDUCATION
Edited Case: How to Treat Venous Leg Ulcers Efficiently.
How Low Can You Go?
Faculty: Mr. Leith Williams
Date: Tuesday, 26 April
Time: 16:50-16:55 BST
Location: Kensington 2, Venous and Lymphatic Challenges
Learning Objectives:
• Understand the benefits of treating advanced venous disease with the ClariVein OC/NTNT technique.
• Receive an update of evidence and guidance on the treatment of venous leg ulcers
• Learn a practical approach to the ClariVein OC device and procedure
Satellite Symposium: When to Stent? Which Stent?
Continuing Experience with the WRAPSODY Cell-Impermeable Endoprosthesis
Faculty: Dr. Andrew Wigham, Dr. Ounali Jaffer, and Dr. Robert Jones
Date: Wednesday, 27 April
Time: 10:00-10:30 AM BST
Location: Richmond, Vascular Access Masterclass
Learning Objectives:
• Understand how to manage patients and how to decide their best treatment options (i.e., treatment algorithm)
• Know more about the current WRAPSODY trial pipeline (FIRST, IDE, and Registry)
• Learn how WRAPSODY can be beneficial and cost effective in daily treatment
HANDS-ON WORKSHOPS
Hands-on Vascular Access Workstation with the Merit WRAPSODY, HeRO Graft, and Surfacer
Faculty: Mr. Gilbert
Date: Tuesday, 26 April
Time: 10:00-15:00 BST
Location: Workshop Wing
Hands-on Venous Workstation with the ClariVein OC and Merit MAK Mini Access Kit
Faculty: Mr. Williams
Date: Wednesday, 27 April
Time: 09:30-15:30 BST
Location: Workshop Wing
At Merit Medical, we are equally dedicated to cutting-edge innovation with our medical products and physician education. Merit is proud to participate in Charing Cross 2022, and we look forward to seeing you in person or virtually!
Merit WRAPSODY™ Endoprosthesis and ClariVein® OC are not approved or available for sale in the United States.
Before using any of the Merit products mentioned above, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.
Merit Medical Recognizes National Kidney Month
March is National Kidney Month, and Merit Medical is committed to empowering the health and wellness of people living with chronic kidney disease and their caregivers. At Merit, our goal is to support the renal health community through a vast array of state-of-the-art therapeutic products, physician education courses, and patient education tools that equip clinicians to make a difference for people living with chronic kidney disease.
According to the National Institutes of Health, approximately 37 million Americans live with chronic kidney disease.1 Although incidences of chronic kidney disease have risen consistently, 9 out of 10 people are not aware of their diagnosis because early-stage kidney disease generally has no symptoms.1
The U.S. Renal Data System 2020 Annual Report cited that approximately 786,000 Americans live with end-stage renal or kidney disease, with 71% (558,000) of those receiving dialysis and 29% (228,000) receiving a kidney transplant.2 People living with end-stage kidney disease require dialysis therapy to regulate body functions, including controlling blood pressure, because their kidneys no longer can.3 Without access to adequate, regular, and affordable dialysis care, people living with end-stage kidney disease will not survive.3
As the number of people impacted by kidney disease continues to increase, Merit’s significant commitment to the renal health community is crucial. Merit is uniquely positioned with hemodialysis and peritoneal dialysis (PD) options for treatments and ancillary products that make a difference for dialysis patients who depend on high-quality care.
Merit Products
Super HeRO®
The Super HeRO Adapter and Support Seal system equips surgeons with standard wall and early cannulation vascular graft options. In addition to reducing hospital admissions due to catheter infections, the Super HeRO helps hospitals and dialysis centers save $3,100 per patient per year when converting catheter-dependent patients to the HeRO graft.
HeRO Graft®
For catheter-dependent patients, or those whose kidney function fails to improve with fistulas or grafts, Merit has engineered a solution: the HeRO Graft, a hemodialysis access graft designed precisely for these patients. Research indicated a 69% reduction in future infections with the HeRO Graft compared to patients receiving catheters.
Surfacer® Inside-Out® Access Catheter System
The Inside-Out approach was developed by John Gurley, M.D., in response to patients with chronically occluded veins. The Surfacer Inside-Out Access Catheter System is inserted through the femoral vein and navigated to an exit point in the right internal jugular vein, preserving the viability of secondary central veins.
Peritoneal Dialysis Catheters
To improve flow rates by 30%, Merit designed Flex-Neck Peritoneal Dialysis Catheters with an internal diameter (ID) that is 35% larger than competitors. Infant catheters come in one and two cuff configurations, and each catheter kit has a unique stenciling system for improved placement accuracy.
CentrosFlo® Hemodialysis Catheters
Featuring self-centering curved tips to promote optimal blood flow and minimize recirculation rates, The Centros (without side holes) and the CentrosFLO™ (with side holes) long-term hemodialysis catheters reach the pinnacle of overall catheter performance. Designed by Dr. Stephen Ash, Merit’s 15F catheters feature a large internal lumen, promoting a flow rate up to 450 mL/minutes.
ProGuide™ Chronic Dialysis Catheters
Designed for patient comfort, ease of insertion, and maintenance, ProGuide Chronic Dialysis Catheters are inserted through a valved peel-away sheath or over-the-wire placements and available in catheter lengths from 19 cm to 50 cm (tip to cuff). Available configurations include standalone catheter, basic kit, complete kit, and complete kit with mini access kit.
Physicians and surgeons look to Merit to provide insightful resources and cutting-edge therapeutic products designed to make a difference for people living with chronic kidney disease. Merit designs and innovates leading products specifically for patients receiving dialysis. For more information on how you can incorporate our dialysis products into your practice, please contact Merit Customer Support.
REFERENCES
- National Institutes of Health. National Kidney Month 2022. Retrieved from https://www.niddk.nih.gov/health-information/community-health-outreach/national-kidney-month
- American Society of Nephrology. (April 2021). Dialysis Care Around The World: A Global Perspective. Retrieved from https://kidney360.asnjournals.org/content/2/4/604
- National Kidney Foundation. Dialysis Info. Retrieved from https://www.kidney.org/atoz/content/dialysisinfo
ReSolve ConvertX® and Treatment of Biliary Obstructions in Pancreatic Cancer: A Physician’s Experience
Pancreatic cancer is the 12th most common cancer worldwide. In the US alone, approximately 60,430 people will be diagnosed with pancreatic cancer this year. Biliary obstructions are a common condition associated with pancreatic cancer. Patients with biliary obstructions often experience discomfort, such as abdominal pain, weight loss, nausea and vomiting, jaundice, and fever. Left untreated, biliary obstructions can lead to serious complications, including infection.
To help treat this patient population, Merit Medical offers the ReSolve ConvertX Biliary Stent System, a unique technology designed for temporary internal drainage in individuals with severe biliary obstructions.
The below case study and physician discussion presents successful treatment of a biliary obstruction with the ReSolve ConvertX in a patient with terminal pancreatic cancer.
CASE STUDY
Patient Profile: Elderly patient with terminal pancreatic cancer. Malignant tumor growth led to obstructions in the right and left hepatic ducts. Traditional bilateral biliary drains were placed to relieve symptoms of jaundice, infections, and abdominal pain.
Complications: Patient experienced frequent accidental pulling on the external portion of the drainage systems and returned to the interventional radiology department for multiple reinterventions. Lesions developed due to bile leakage through the existing track and irritating the skin. Patient also expressed that the two external bags were burdensome.
Procedure: Both biliary drains were removed over an Amplatz-style wire and were replaced with the ReSolve ConvertX Biliary Stent System. After both ReSolve ConvertX drains were in place, they were each converted, leaving only the stent portions in place.
Outcomes/Results: After placement, patient was happy with the treatment and able to experience relief and an improvement in quality of life.
Sample flouro of ReSolve ConvertX Biliary Stent Placement
Listen in as Mark H. LeQuire, MD, FACR, Diagnostic, Vascular & Interventional Radiologist at Montgomery Radiology Associates, discusses this case further in an in-depth interview.
ReSolve ConvertX Tip
- When placing bilaterally, ensure both systems are in place before stent conversion. If the first drain is converted to a stent before the second one is in place, it increases the risk of dislodging the first stent while placing the second.
Learn more about the advantages the ReSolve ConvertX can offer your patients and practice by visiting the product page or contacting the Merit Customer Support Center.
Continuing Education: Why It’s Vital to Improving Patient Care
Think Education™ proctors discuss the purpose continuing education serves in an evolving medical industry and how the Think Education program is paving the way for better learning opportunities now and into the future.
The medical field is a continual evolution of new procedures and innovations. To bring these tools and techniques to practice, physicians take on the role of lifelong learners, making continuing education an integral part of their profession.
According to the American Association of Continuing Medical Education, continuing education is “crucial to the prosperity of healthcare providers, as it allows them to learn and discover viable ways to improve on the patient care they deliver and effectively manage a career in the ever-changing landscape of the medical industry.” 1
“Physician education allows us to remain at the forefront of knowledge,” says Darren Klass, MD, PhD, MRCS, FRCR, FRCPC, Think Radial® Proctor. “It has a dramatic impact on patient care in that it allows physicians to provide the latest treatment. In many instances, the procedure itself may not fundamentally change; however, new techniques and equipment that make the procedure safer and more effective can improve patient outcomes.”
Not only does continuing education keep physicians informed, it also helps to ensure patients are, too. Being aware of all treatment options can mean the difference between undergoing a minimally invasive procedure or conventional surgery. Utilizing less invasive techniques can minimize risk to the patient, reduce pain as well as recovery time in comparison to open surgery. 2
“Even if physicians are not bringing new skills and developments directly into their own working environment, the awareness of new alternatives is valuable,” explains Ferdinand Kiemeneij, MD, PhD, Think Radial Proctor. “Patients will benefit by either receiving state-of-the-art treatment, or they are at least aware of alternatives if the physician involved informs them properly.”
Merit Medical’s Think Education program provides physicians with quality instruction that focuses on cutting-edge interventional technology and techniques, facilitating advanced therapies designed to provide a less invasive approach to treatment that results in better patient outcomes.
Program topics include interventional techniques for airway stenting, the implantation of LV leads, and minimally invasive treatment of pathologic vertebral fractures and metastatic spinal tumors. Other course topics include embolization for the treatment of symptomatic benign prostatic hyperplasia, peritoneal dialysis implantation, radial and distal access, and wire-free tumor localization. Explore Merit’s courses here.
Designed and taught by physicians, each course immerses attendees in a number of ways, including didactic presentations, taped or live cases, and state-of-the-art, hands-on training. Encompassing all aspects of a procedure or disease state, Think Education courses provide physicians with the up-to-date knowledge they need to immediately put what they learn into practice. Both virtual and on-demand courses are available.
“The courses evolve each time they are presented in order to provide physicians with the latest data and experience, presented in an unbiased way that is first and foremost about improving patient care,” Dr. Klass says. “Probably the biggest impact the Think courses have is their clear message of intercollegiate collaboration. Physicians are able to listen to experts speak on their respective fields—which is unique to the Think Education program.”
“Think Education is an invaluable asset to the medical community,” explains Brett Parkinson, MD, Think Wire-Free™ Proctor. “It provides opportunities for physicians to learn in a friendly, relaxed environment, and because course topics involve cutting-edge technology, attendees come away knowing they have added the latest treatment options to their armamentarium of care.”
“As a proctor for Think Education programs, I believe physician-to-physician interaction gives attendees confidence that they are getting experienced thought leaders in their field,” says Michael Hallisey, MD, Think Spine™ Proctor. “This gives them the chance to expand their knowledge and improve their medical practice.”
A challenge physicians have faced in continuing their education and improving their practice was doing so in the face of a pandemic. It required rethinking traditional methods of instruction to minimize in-person interaction and spread of the disease. To make this undertaking easier, retaining real-time personal interaction helped online learning feel less isolating, fostering effective and sustainable experiences.3
“The medical education of today will be of historical interest tomorrow. This has been evident, as the old educational paradigm shifted abruptly from large gatherings to individual learning in the comfort of one’s home,” Dr. Parkinson adds. “Think Education was able to effectively pivot from in-person seminars to virtual learning.”
As continuing education adapts to the changing needs of physicians, it brings with it the opportunity to influence and improve future opportunities to learn, serving as a catalyst for better programs that have a broader reach.
“Physician education will continue to expand in the online format in the future. This can allow top physicians to share their expertise with a larger part of the world,” Dr. Hallisey says. “We all want more confidence and skill in treating patients. A well-educated physician can have that.”
Learn more about Merit’s Think Education program and sign up for an upcoming course today.
REFERENCES
1. American Association of Continuing Medical Education. 2020. “Importance of CME.” https://aacmet.org/cme/importance-of-cme/
2. Johns Hopkins Medicine. 2021. “What Is Vascular and Interventional Radiology?” https://www.hopkinsmedicine.org/interventional-radiology/what_is_IR.html
3. Chirag V et al. 2020. “Socially Distant Medical Education in the Face of COVID-19.” Med Sci Educ Oct 21: 1–3. PMID: 33106763
ReSolve ConvertX® Simplifies Drainage Care, Limits Patient Exposure
To limit coronavirus exposure to patients and healthcare workers, healthcare facilities are decreasing the number of procedures performed as well as the length of procedure time for those that remain scheduled. This includes replacing surgical care with less-invasive interventional radiology procedures.
New hospital protocols may prove challenging for patients who need multistep care, as seen with individuals who suffer with severe ureteral or biliary obstructions. Traditionally, these patients require two separate interventional procedures to successfully place a temporary internal drainage: a first procedure to place a drainage catheter and a second to place a stent.
To simplify treatment for these patients, Merit Medical offers a temporary internal nephroureteral and biliary drainage stent system called the ReSolve ConvertX Stent System. A less-invasive option than conventional treatment, the ReSolve ConvertX completely eliminates the need for a second drain-to-stent procedure. Instead, stent conversion can be done in an office or at bedside in less than one minute.1
WATCH HOW THE RESOLVE CONVERTX WORKS
Eliminating a second interventional procedure has several advantages, particularly in the present healthcare crisis. Without the need for a lengthy, additional drain-to-stent procedure, hospital visits may be shorter for patients,2 potentially resulting in less risk of exposure to other patients, physicians, and hospital staff. Because treatment with the ReSolve ConvertX can be completed in a less-intense care setting, it can free up physicians and hospital staff to care for an increasing caseload outside of the interventional radiology suite. This may also leave the interventional radiology suite open for an influx of new interventional cases.
The ReSolve ConvertX is also designed with other clinical benefits in mind, such as reduced procedural challenges for the patient. Furthermore, with fewer procedures, there is less radiation exposure for patients, physicians, and hospital staff.
FIRST IMPRESSIONS OF RESOLVE CONVERTX
The Impact of COVID-19 on Breast Cancer Management
SCOUT Localization can help alleviate future workflow challenges
As a result of the effect of the COVID-19 pandemic in the US, screening, diagnostic exams, and surgical procedures are being severely restricted or postponed at hospitals and breast centers across the country. This is causing a disruption never experienced before in the diagnosis and treatment of the 325,000 projected cases of breast cancer in 2020 in the US.1
These delays and closures will impact care delivery well into the foreseeable future. While this health crisis clearly needs immediate management, we also need to think long term on how to effectively manage the backlog of breast cancer patients once restrictions have been lifted.
Merit Oncology is connecting physicians across the county to share their experiences, challenges, and solutions with managing breast patients during COVID-19. Merit Café is a forum for healthcare providers to come together to share best practices and experiences in an online, interactive forum moderated by a radiologist and a surgeon. Discussion focuses on relevant topics including triaging breast patient care during the COVID-19 pandemic, procedure efficiency, minimizing patient/provider exposure, and planning for downstream challenges anticipated post-pandemic.
Joining Merit for this Q&A is Vincent Reid, MD, Surgical Oncologist at Mercy’s Hall-Perrine Cancer Center, Cedar Rapids, Iowa and one of the first moderators of Merit Café
Does your institution have guidelines established for the surgical management of breast cancer patients?
There has been guidance published from different organizations and societies on the management of elective surgeries. It is important to note that they all share the common goal of minimizing patient and physician exposure and preserving personal protective equipment (PPE). The guidelines are mostly based on the assumption of a low to moderate COVID-19 census at your facility. Once a surge of COVID-19 occurs, the guidelines become more restrictive. The guidelines are also constantly being updated, so it is important to stay on top of the latest revisions.
At the current time, in our community, we are at that low to moderate stage. However, as I talk to colleagues on Merit Café from other parts of the country, particularly on the East coast, their situation is very different. Having the opportunity to learn what they are doing has been helpful to me in planning for different scenarios.
Access the most recent guidelines from the COVID-19 Pandemic Breast Cancer Consortium, comprised of representatives from the American Society of Breast Surgeons (ASBrS), the National Accreditation Program for Breast Centers (NAPBC), the National Comprehensive Care Network (NCCN), the Commission on Cancer (CoC), and American College of Radiology (ACR) here.
Based on your hospital’s and your region’s exposure, what are some of the plans you are putting into place now to help patients and staff when restrictions are lifted at your hospital?
Our number one priority is to help ease the stress and anxiety of our patients during this difficult time, not only about their cancer but now COVID-19. All our breast cancer patients are being evaluated by a multidisciplinary group to develop a recommended care plan. Some patients are having surgery delayed and for those patients where it is appropriate, they are going to either neoadjuvant chemotherapy (NAC) or endocrine therapy prior to surgery. We are localizing these patients with SCOUT®, which can safely and effectively be placed, even though they will not go surgery for several months. This will streamline the process once they are ready to go to surgery. If immediate surgery is indicated those patients proceed to surgery.
Where appropriate, we are also localizing with SCOUT at time of biopsy. At Mercy, a number of our patients drive long distances for treatment. When we can eliminate an entire procedure, we eliminate a travel day, decrease patient and physician interaction, and preserve PPE. That is significant all around.
How do you anticipate the strategies you are implementing now will help with overrun schedules in all hospital departments?
I see two things, first the placement of SCOUT in our surgical patients. Our radiology department is going to be slammed just catching up with routine mammography screening. Patients who have been waiting for cancer surgery for 2-4 months are not going to want to wait any longer than needed if they have to go and be localized prior to surgery. They will get very impatient if radiology scheduling resulted in an additional delay.
The second is telemedicine. Our cancer program was about two years out on the horizon for implementing a meaningful telemedicine program. Now fast forward to a pandemic and we have progressed leaps and bounds in this implementation. We are conducting video telemedicine consultations with patients now, so they do not have to be delayed waiting for a consult. It is an excellent tool and allows me quality time with my patients discussing options.
Have you seen any unexpected outcomes of the COVID-19 restrictions?
I am seeing more patients opting for a lumpectomy over mastectomy. Clearly there are clinical cases where a mastectomy is the only option, but with the current surgical restrictions we are not able to do reconstruction – that part of the procedure is being delayed. Women who are candidates for lumpectomy, who were leaning toward a mastectomy of their own choice are now opting for a lumpectomy.
The outcome that I find most enlightening is that we are all united in a powerful way. I am virtually connecting with colleagues, that I might have never had the opportunity to meet, and we are sharing and learning from each other. I look forward to the day our medical societies come together again, and we can all meet in person.
What are you telling your breast cancer patients during this difficult time?
I think the most important message for patients is the reassurance that no matter what the recommended course of treatment is they are not being put at risk. We are thoughtfully evaluating all the options, and even in the COVID-19 environment as we are working to keep everyone safe, we are not compromising their cancer care. I also reassure them that once restrictions are lifted everything possible has been done to assure, they can move on to the next step of treatment as quickly as possible.
Merit Recognizes Infection Prevention Week with a Strong History of Keeping Clinicians and Patients Safe
Today marks the start of International Infection Prevention Week, a worldwide awareness event aimed at highlighting ways to stop the spread of healthcare-associated infections (HAIs). At any given time, about one in 25 inpatients have an infection related to hospital care.1 HAIs may lead to sepsis or even death,2 prompting healthcare providers to take preventative action to protect patients. Through a number of safety and infection prevention products and education programs, Merit Medical strives to make the healthcare setting safer for patients and healthcare professionals.
In 1987 Merit was built on a safety product: a safer and stronger disposable syringe. Over the past 32 years, we’ve continued this legacy of innovation, developing best-in-class safety and infection prevention devices that benefit patients, healthcare professionals, and overall health systems.
Many HAIs can be prevented with proper infection prevention practices. We’re pleased to offer products and training programs that can help hospitals reduce their risk.
DualCap® Disinfection & Protection System
A shining star of our commitment to infection prevention is the DualCap® Disinfection & Protection System, a unique disinfecting cap system for use on both the male luer connector at the end of the IV tubing and the needle-free valve. Clinical evidence shows that the male luer connector can become contaminated up to 37% and the needle-free valve up to 24%, routinely causing vascular device cross-contamination.3
The DualCap — which was designed by nurses — helps to solve these problems via two color-coded, easy-to-grasp caps with built-in disinfecting sponges saturated with 70% isopropyl alcohol. Just twist onto the male luer connector and needle-free valve to disinfect and protect until access is required. Within 30 seconds, the DualCap not only disinfects but also provides a physical barrier to contamination for up to 7 days.4*
Learn more about how the DualCap helps to protect patients.
Safety Products
Other products designed to keep clinicians and patients safe include quick and safe fluid waste elimination systems, such as the BackStop®, MiniStop®, BackStop+™, and MiniStop+™. Our temporary sharps holders, the ShortStop® and ShortStop Advantage®, are intuitively designed to prevent sharps injuries. And PAL™ – Pen and Labels and Medallion® Syringes streamline medication labeling, helping to facilitate compliance with national safety goals.
Explore all of Merit’s Safety & Waste Management and Infection Prevention products.
Educational Opportunities
We also offer the Think Safety and Infection Prevention program, a series of educational opportunities designed to help clinicians learn about techniques, tools, and methods that can improve patient outcomes and prevent HAIs as well as costly medical errors. Attendees can participate in live and recorded webinars and educational events throughout the year and learn the latest patient and clinician safety and infection prevention.
Merit is happy to recognize International Infection Prevention Week and be your partner in keeping hospitals and healthcare settings safe.
REFERENCES
1. Office of Disease Prevention and Health Promotion. (2019 Oct 7). Health care-associated infections. Retrieved from https://health.gov/hcq/prevent-hai.asp
2. Centers for Disease Control and Prevention. (2017 Dec 4). Healthcare-associated infections (HAIs). Retrieved from https://www.cdc.gov/winnablebattles/report/HAIs.html
3. Lopansri BK, et al. Does the Partner Matter? (SHEA 2011, Paper 4539).
4. DualCap® IV Pole StripsTM Disinfectant Caps for Male Luers and Luer Access Valves Instructions for Use. Catheter Connections.
* Under normal conditions if not removed
Merit Addresses Growth in Home Dialysis Care with Patient and Physician Tools
There has been a recent shift in kidney care with both industry leaders and the White House showing support of home dialysis. This forward momentum is due to several advantages home dialysis offers patients, such as lower mortality rates,1 flexible treatment schedules,2 and reduced cost.3 Merit Medical is pleased to support this transition by providing dialysis patient education, clinician training, and a number of therapeutic products.
Heading the movement are international industry leaders DaVita® Kidney Care and Fresenius Kidney Care with an initiative called 20% by 2020, a program that aims to have 20% of dialysis patients on home dialysis therapy by the year 2020. Both DaVita and Fresenius provide two types of home dialysis options: peritoneal dialysis (PD) and hemodialysis.
“The initiative is important from several standpoints,” says John H. Crabtree, MD, general surgeon, chair of PD University for Surgeons-North America, and visiting clinical faculty at Harbor-UCLA Medical Center in Torrance, CA. “Number one, patients do better on home dialysis.”
Patients on PD therapy in particular, a group that comprises the majority of the home dialysis-treatment population, “have improved survival over the early years on treatment,” Dr. Crabtree told Merit Medical.4 Moreover, for individuals who receive a kidney transplant, “the results tend to be better when they were on peritoneal dialysis prior to the surgery as opposed to hemodialysis.”5
Home dialysis also offers greater autonomy. Because patients are properly trained and therapy can be done overnight, home dialysis allows for a regular work schedule.3 Moreover, the average cost of care for home dialysis is less.3 PD in particular, Dr. Crabtree went on to explain, is approximately $15,000 less per patient per year compared to hemodialysis.6
The White House recently announced a new government-sponsored payment approach for treating kidney disease that favors lower cost home dialysis. The U.S. Centers for Medicare and Medicaid Services is considering a trial program design that would improve care in the early stages of kidney disease, increase access to kidney transplants, and favor home dialysis over clinic-based treatment.3 It is particularly looking at the benefits of PD.3
Despite these advantages and the fact that many physicians believe 25%–35% of patients would do better on home dialysis therapy, the number of people receiving home dialysis in the US still remains low, with only 7% receiving PD and less than 1% choosing home hemodialysis.7 The 20% by 2020 initiative plans to change this through several avenues.
“The way that we can drive this is by improving patient education…Many patients aren’t provided information about home dialysis,” Dr. Crabtree explains. In addition to patient education, Dr. Crabtree says many physician education programs lack the training needed to take care of PD patients. “[I]t’s important to provide courses [and] educational opportunities that allow them to have hands-on training.”
Merit Medical is ready to address these needs through its Ask4PD™ patient education site and ThinkDialysisAccess™ hands-on physician training experiences. Merit also offers high-quality dialysis products, such as the Flex-Neck® Peritoneal Dialysis Catheter, a premium catheter that allows for up to 30% higher flow rates than other catheters currently on the US market.8
The support for home dialysis is expanding. By providing the tools and education needed to advance the 20% by 2020 initiative, Merit shows its ongoing evolution as a healthcare company as well as its vision to continually find ways to improve patient care.
Watch Dr. Crabtree’s interview to learn more about the benefits of home dialysis and how Merit supports it.
Dr. Crabtree is a paid consultant of Merit Medical.
REFERENCES
- DaVita® Kidney Care. (n.d.). Top 5 benefits of home dialysis treatment. Retrieved from https://www.davita.com/treatment-services/home-dialysis/home-benefits/top-5-benefits-of-home-dialysis-treatment.
- Fresenius Kidney Care. (2019). Learn more about home dialysis treatment options. Retrieved from https://www.freseniuskidneycare.com/ckd-treatment/benefits-of-home-dialysis.
- Copley, C., & Humer, C. (2019, March 3). U.S. seeks to cut dialysis costs with more home care versus clinics. Retrieved from https://www.reuters.com/article/us-usa-healthcare-dialysis/us-seeks-to-cut-dialysis-costs-with-more-home-care-versus-clinics-idUSKCN1QL0G6.
- Teixeira, J.P., Combs, S. A., & Teitelbaum, I. (2015). Peritoneal dialysis: Update on patient survival. Clin Nephrol, Jan;83(1):1-10.
- Joachim, E., Gardezi, A. I., Chan, M. R., et al. (2017). Association of pre-transplant dialysis modality and post-transplant outcomes: A meta-analysis. Perit Dial Int, May-Jun;37(3):259-265.
- United States Renal Data System. (2018). 2018 annual data report (Chapter 9: Healthcare expenditures for persons with ESRD). Retrieved from https://www.usrds.org/2018/view/v2_09.aspx
- DaVita Kidney Care. (n.d.). Majority of nephrology professionals prefer home dialysis. Retrieved from https://www.davita.com/treatment-services/home-dialysis/recommended-approach.
- Data on file.
Recap of SIR 2019
Announcing New Product Innovations and Education Presentations at SIR 2019 – Booth 349
As the pioneers of minimally invasive treatment, you are innovators.1 And Merit Medical is pleased to be your industry partner in innovative healthcare. This year at SIR 2019, we will introduce several new innovative products and technologies in the areas of venous therapy, interventional spine, embolics, biopsy, drainage, and radial access. We are also pleased to provide several in-booth education presentations and hands-on opportunities to further your learning experience at SIR.
Innovation Education Series at the Merit Medical Booth
The Evolution of Radial Access – The Science and Practice of Distal Transradial
- Date: Sunday, March 24, 2019
- Time: 12:00 – 1:00 PM *Meet and Be Educated: Lunch provided; first come, first served.
Steerability in Single Access Approach for Vertebral Augmentation
- Date: Monday, March 25, 2019
- Time: 10:00 – 10:30 AM
How Low Can You Go? A Paradigm Change in the Treatment of Venous Insufficiency
- Date: Monday, March 25, 2019
- Time: 12:00 – 1:00 PM *Meet and Be Educated: Lunch provided; first come, first served.
Advanced Localization Techniques; Breast Cancer – From Biopsy to Lymph Nodes
- Date: Tuesday, March 26, 2019
- Time: 10:00 – 10:30 AM
Targeted RF Ablative Therapy in Metastatic Spine Disease: Steerability and Clinical Evidence
- Tuesday, March 26, 2019
- Time: 12:00 – 1:00 PM *Meet and Be Educated: Lunch provided; first come, first served.
* The content of these sessions is not part of the SIR 2019 Annual Scientific Meeting as approved by the Annual Scientific Meeting Committee. Merit Medical is hosting this lunch in accordance with the AdvaMed Code of Ethics.
New Product Innovations and Hands-on Learning
Venous Therapy:
- Merit Medical recently acquired the ClariVein® IC Infusion Catheter
- Hands-on Opportunity: Experience single-handed operation of the ClariVein while learning about its many patient and operator advantages
- Learn more about Merit’s Access Kits and Packs, complete solutions to access the vascular system
Interventional Spine:
- Explore the Osseoflex® SB Steerable and Straight Balloons, for access to the entire vertebral body and cavity creation using a unipedicular or bipedicular approach
- Discover Osseoflex® SN Steerable Needles, for access to the vertebral body via a unipedicular approach
- Find out about upcoming ThinkInterventionalSpine™ physician education opportunities
Embolics:
- EmboCube™ Embolization Gelatin, available in two sizes (2.5 mm and 5.0 mm diameters), pre-loaded into syringes
- Hands-on Opportunity: UFE and PAE kiosk, for clinical resources and patient-facing tools
- Hands-on Opportunity: PAE-simulator training
Biopsy and Localization:
- New and Improved CorVocet™ Biopsy System, designed to cut a full core of tissue and provide large specimens
- Merit Medical recently acquired the SAVI SCOUT®, for wire-free radar localization of target tissue during breast cancer care
- Hands-on Opportunity: Experience the SAVI SCOUT
Drainage:
- Learn about the Aspira® Drainage System, designed to help patients drain fluid and manage symptoms without repeated trips to the hospital
- New Aspira® Drainage System Demo Kit and 24-hr Patient Hotline, support pieces for patients using the Aspira Drainage System
Radial Access:
- New PreludeSYNC DISTAL™, a hemostasis device designed for “snuff box” access sites (distal radial artery)
- Discover the Prelude IDeal™ Hydrophilic Sheath Introducer, designed with increased resistance to kinking and compression
REFERENCES
- Society of Interventional Radiology. (n.d.). Nonsurgical interventional radiology procedures offer less risk, less pain and less recovery time compared to open surgery. Retrieved from https://www.mirmss.org/uploads/2/0/7/9/20795846/about_interventional_radiology.pdf